Fluorescent Reagents Evaluated for Vulvovaginal Candidiasis Diagnosis
|
By LabMedica International staff writers Posted on 29 Jul 2021 |

Image: The images under fluorescence microscopy and light microscopy with four methods. A-D, show Candida albicans, and E-H, show C. glabrata; both the fungal color and the structure in FB 85 and CFW were clear and easily recognized from the background squamous cells compared with the KOH method (Photo courtesy of Capital Medical University)
Vulvovaginal candidiasis (VVC) is a common vaginitis in females, which is estimated to be the second most common cause of vaginitis after bacterial vaginosis. Vulvovaginal candidiasis affects around 70%–75% of all women during their childbearing age, and is considered to be an important public health problem.
The morbidity associated with VVC makes it a major cause of causing pain, great discomfort, mental distress, anxiety, altered self-esteem, impairing work performance and interfering with sexual and affective relations. The signs of VVC are typically characterized white clumpy discharge. The commonly used diagnostic method is 10% potassium hydroxide (KOH) smear microscopy.
Clinical Laboratorians at the Capital Medical University (Beijing, China) and their associates recruited patients according to the symptoms and the signs included vaginal discharge, irritation, itching, and/or odor, and who were suspected of having VVC, from October 2018 to February 2019. A total of 110 specimens were obtained with suspected VVC, aged 19–60 years, with an average age of 30.99 ± 7.77 years.
The team used different methods to detect VVC: fungal culture, fluorescent microscopy observation with Calcofluor White (CFW) and fluorescent brightener 85 (FB 85). The swabs were smeared on two separate slides, one with a drop of CFW, the other with a drop of 0.1% FB 85. The secretions gathered from the dilator were smeared on a third slide and examined using KOH under a light microscopy by adding a drop of 10% KOH to the slide. Microscopic observations were conducted using an Olympus CX23 LEDRFSIC microscopy (Olympus Co., Ltd, Tokyo, Japan) using either the 340–380 nm ultraviolet light mode or the visible light mode.
The scientists reported that in the 110 specimens, 75/110 (68.2%) were positive by the KOH method, 71/110 (64.5%) were positive by the CFW fluorescent method, 68/110 (61.8%) were positive by the FB 85 fluorescent method, and 77/110 (77%) were positive by the fungal culture method. In the 110 specimens, the specificity of the three methods was 100%. The sensitivity, and accuracy of CFW were the highest, followed by KOH method and FB 85 was the lowest.
For the VVC caused by Candida glabrata, yeast form was always observed, which is very clear with the CFW method and the FB 85 method, but was not easily found by light microscopy. The team observed a fade time of two fluorescent reagents under daylight in the room environment and due to the crystals and the faint fluorescence, it was harder to distinguish the fungi from the 24 hours specimen than the fresh specimen.
The authors concluded that they could find pathogenic fungi more quickly with fluorescent method in diagnosis of VVC. Both CFW and FB 85 were good reagents. FB 85 is a new fluorescent reagent for the diagnosis of VVC and other fungal affection diseases and has potential value for clinical applications. The study was published on July 12, 2021 in the Journal of Clinical Laboratory Analysis.
Related Links:
Capital Medical University
Olympus Co., Ltd
The morbidity associated with VVC makes it a major cause of causing pain, great discomfort, mental distress, anxiety, altered self-esteem, impairing work performance and interfering with sexual and affective relations. The signs of VVC are typically characterized white clumpy discharge. The commonly used diagnostic method is 10% potassium hydroxide (KOH) smear microscopy.
Clinical Laboratorians at the Capital Medical University (Beijing, China) and their associates recruited patients according to the symptoms and the signs included vaginal discharge, irritation, itching, and/or odor, and who were suspected of having VVC, from October 2018 to February 2019. A total of 110 specimens were obtained with suspected VVC, aged 19–60 years, with an average age of 30.99 ± 7.77 years.
The team used different methods to detect VVC: fungal culture, fluorescent microscopy observation with Calcofluor White (CFW) and fluorescent brightener 85 (FB 85). The swabs were smeared on two separate slides, one with a drop of CFW, the other with a drop of 0.1% FB 85. The secretions gathered from the dilator were smeared on a third slide and examined using KOH under a light microscopy by adding a drop of 10% KOH to the slide. Microscopic observations were conducted using an Olympus CX23 LEDRFSIC microscopy (Olympus Co., Ltd, Tokyo, Japan) using either the 340–380 nm ultraviolet light mode or the visible light mode.
The scientists reported that in the 110 specimens, 75/110 (68.2%) were positive by the KOH method, 71/110 (64.5%) were positive by the CFW fluorescent method, 68/110 (61.8%) were positive by the FB 85 fluorescent method, and 77/110 (77%) were positive by the fungal culture method. In the 110 specimens, the specificity of the three methods was 100%. The sensitivity, and accuracy of CFW were the highest, followed by KOH method and FB 85 was the lowest.
For the VVC caused by Candida glabrata, yeast form was always observed, which is very clear with the CFW method and the FB 85 method, but was not easily found by light microscopy. The team observed a fade time of two fluorescent reagents under daylight in the room environment and due to the crystals and the faint fluorescence, it was harder to distinguish the fungi from the 24 hours specimen than the fresh specimen.
The authors concluded that they could find pathogenic fungi more quickly with fluorescent method in diagnosis of VVC. Both CFW and FB 85 were good reagents. FB 85 is a new fluorescent reagent for the diagnosis of VVC and other fungal affection diseases and has potential value for clinical applications. The study was published on July 12, 2021 in the Journal of Clinical Laboratory Analysis.
Related Links:
Capital Medical University
Olympus Co., Ltd
Latest Technology News
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
- AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
- AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection
- AI Model Achieves Breakthrough Accuracy in Ovarian Cancer Detection
- Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
- Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement

- Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
- Viral Biosensor Test Simultaneously Detects Hepatitis and HIV
- Acoustofluidic Device to Transform Point-Of-Care sEV-Based Diagnostics
- AI Algorithm Assesses Progressive Decline in Kidney Function
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more








